Evonik aligns two business lines with new growth strategy

Businesses outside core areas are to be sold or discontinued

16-Oct-2024 - Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. The remaining businesses outside these cores are to be sold to new owners or incorporated ...

A cellular model system for drug development in fatty liver disease

A 3D in vitro cell culture model as a basis for the development of new treatment strategies for one of the most common diseases in industrialized nations

12-Sep-2024 - Scientists from the Medical Faculty Mannheim, Heidelberg University have developed a model system that can be used to test the efficacy of drugs for fatty liver disease. It is a three-dimensional (3D) in vitro cell culture system based on primary human liver parenchymal cells (hepatocytes). The ...

Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...

Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries

This customer-oriented approach is dedicated to accelerating the biotech journey from R&D up to clinical production

29-Feb-2024 - Capricorn Scientific GmbH and ExcellGene SA have established a strategic partnership within the biotechnology sector. Applying their collective expertise and capabilities, the collaboration seeks to help customers by optimizing processes, developing products, and offering solutions in ...

Neuromuscular 2D model for drug research

21-Dec-2023 - In neuromuscular diseases, the interaction between neurons and muscle cells is disrupted. Researchers led by Mina Gouti are now able to simulate this in 2D in a culture dish. The approach is well suited for high-throughput screening in drug research, they write in Nature Communications. Around ...

Programmable DNA hydrogels for advanced cell culture and personalized medicine

21-Aug-2023 - The team of Dr. Elisha Krieg at the Leibniz Institute of Polymer Research Dresden has developed a dynamic DNA-crosslinked matrix (DyNAtrix) by combining classical synthetic polymers with programmable DNA crosslinkers. DNA’s highly specific and predictable binding gives researchers unparalleled ...

IUTA and Green Elephant win second LABVOLUTION AWARD

11-May-2023 - Making everyday laboratory processes run more smoothly, increasing sustainability, improving efficiency and reducing costs – this is what the second LABVOLUTION AWARD was all about. The award ceremony took place on 10 May, during the second day. Alongside the Institut für Umwelt & Energie, ...

Model system provides insight into the growth of pancreatic tumors

Researchers develop innovative organoid model to study pancreatic cancer

07-Oct-2022 - Researchers at the Technical University of Munich (TUM) have developed a novel model system that can be used to precisely track the growth steps and three-dimensional arrangement of pancreatic cancer cells. It also provides the basis for testing and developing therapeutic approaches. Pancreatic ...

faCellitate, a BASF spin-off, raises 3.7 million euros in first financing round

First product facilitates reliable and reproducible 3D cell cultivation

12-Sep-2022 - Mannheim-based life science startup faCellitate has successfully raised 3.7 million Euro in its closing of seed funding. On board are well-known investors such as SARSTEDT, HTGF, R3 Consulting, ROI Verwaltungsgesellschaft, ARVE Capital and Chemovator. The faCellitate team under the leadership of ...